knowledge -WSS

knowledge

author：knowledge 2025-10-01 18:23:00 - browse：6845

Sammy Kimball for STAT

Can unicorns survive without data? Did biotech get over its skis? And what is going on at Biogen?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Allison DeAngelis joins us to share her reporting on how the handsomely funded Laronde Therapeutics, billed as “Moderna 2.0,” ran into behind-the-scenes problems with its scientific data. We also discuss how Biogen’s boardroom scandal has roiled a company that was supposed to be entering a new era.

For more on what we cover, here’s the Laronde story; here’s the latest on Biogen; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： FDA early review: GLP

knowledge

WSS

First transplant of an entire human eye performed

At JPM 2024, hospital systems pitch financial strength to investors

Weight loss drugs should be covered by insurers, AMA says

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

White House drug czar issues call for 'recovery

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

focus

knowledge

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

Boston Scientific acquires urology company Axonics for $3.7 billion

State Dept. review finds Biden bears some blame for Afghanistan failures

Weight loss drugs should be covered by insurers, AMA says

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Gene therapy denied for Afghan refugee whose father aided U.S.

The cancer drug shortage isn’t new — and neither are the solutions

Ventyx halts psoriasis drug development after lackluster trial results

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medicare Advantage coverage denials need scrutiny, senators say

explore

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Study suggests Covid rebound is far more common with Paxlovid than without

Weight loss drugs should be covered by insurers, AMA says

Ohio still needs to do more to protect the right to abortion

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

What health policies could hitch a ride on a spending bill?

focus

leisure time

knowledge

explore